Figure 4.
Inhibition of mTOR in cancer and bone effects: Everolimus, Vitamin D and Denosumab together contribute to inhibiting cancer progression and modulate osteoclastogenesis.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.